Management of epithelial precancerous conditions and early
neoplasia of the stomach (MAPS III): European Society of
Gastrointestinal Endoscopy (ESGE), European Helicobacter and
Microbiota Study Group (EHMSG) and European Society of
Pathology (ESP) Guideline update 2025

J 2025

Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025

DINIS-RIBEIRO, Mário; Diogo LIBÂNIO; Hugo UCHIMA; Manon C W SPAANDER; Jan BORNSCHEIN et al.

Základní údaje

Originální název

Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025

Autoři

Vydání

Endoscopy, STUTTGART, GEORG THIEME VERLAG KG, 2025, 0013-726X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30219 Gastroenterology and hepatology

Stát vydavatele

Německo

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 12.800 v roce 2024

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/25:00140898

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

early neoplasia of the stomach; epithelial precancerous conditions

Štítky

14110223, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 20. 2. 2026 07:32, Mgr. Tereza Miškechová

Anotace

V originále

At a population level, the European Society of Gastrointestinal Endoscopy (ESGE), the European Helicobacter and Microbiota Study Group (EHMSG), and the European Society of Pathology (ESP) suggest endoscopic screening for gastric cancer (and precancerous conditions) in high-risk regions (age-standardized rate [ASR] > 20 per 100 000 person-years) every 2 to 3 years or, if cost–effectiveness has been proven, in intermediate risk regions (ASR 10–20 per 100 000 person-years) every 5 years, but not in low-risk regions (ASR < 10). ESGE/EHMSG/ESP recommend that irrespective of country of origin, individual gastric risk assessment and stratification of precancerous conditions is recommended for first-time gastroscopy. ESGE/EHMSG/ESP suggest that gastric cancer screening or surveillance in asymptomatic individuals over 80 should be discontinued or not started, and that patients’ comorbidities should be considered when treatment of superficial lesions is planned.

Citovat

DINIS-RIBEIRO, Mário; Diogo LIBÂNIO; Hugo UCHIMA; Manon C W SPAANDER; Jan BORNSCHEIN; Tamara MATYSIAK-BUDNIK; Georgios TZIATZIOS; João SANTOS-ANTUNES; Miguel AREIA; Nicolas CHAPELLE; Gianluca ESPOSITO; Gloria FERNANDEZ-ESPARRACH; Lumír KUNOVSKÝ; Mónica GARRIDO; Ilja TACHECI; Alexander LINK; Pedro MARCOS; Ricardo MARCOS-PINTO; Leticia MOREIRA; Ana Carina PEREIRA; Pedro PIMENTEL-NUNES; Marcin ROMANCZYK; Filipa FONTES; Cesare HASSAN; Raf BISSCHOPS; Roger FEAKINS; Christian SCHULZ; Konstantinos TRIANTAFYLLOU; Fatima CARNEIRO a Ernst J KUIPERS. Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025. Endoscopy. STUTTGART: GEORG THIEME VERLAG KG, 2025, roč. 57, č. 05, s. 504-554. ISSN 0013-726X. Dostupné z: https://doi.org/10.1055/a-2529-5025.

@article{2487017,
   author = {DinisandRibeiro, Mário and Libânio, Diogo and Uchima, Hugo and Spaander, Manon C W and Bornschein, Jan and MatysiakandBudnik, Tamara and Tziatzios, Georgios and SantosandAntunes, João and Areia, Miguel and Chapelle, Nicolas and Esposito, Gianluca and FernandezandEsparrach, Gloria and Kunovský, Lumír and Garrido, Mónica and Tacheci, Ilja and Link, Alexander and Marcos, Pedro and MarcosandPinto, Ricardo and Moreira, Leticia and Pereira, Ana Carina and PimentelandNunes, Pedro and Romanczyk, Marcin and Fontes, Filipa and Hassan, Cesare and Bisschops, Raf and Feakins, Roger and Schulz, Christian and Triantafyllou, Konstantinos and Carneiro, Fatima and Kuipers, Ernst J},
   article_location = {STUTTGART},
   article_number = {05},
   doi = {https://doi.org/10.1055/a-2529-5025},
   keywords = {early neoplasia of the stomach; epithelial precancerous conditions},
   language = {eng},
   issn = {0013-726X},
   journal = {Endoscopy},
   title = {Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025},
   url = {https://www.esge.com/management-of-epithelial-precancerous-conditions-and-early-neoplasia-of-the-stomach-maps-iii-esge-ehmsg-esp-guideline-update-2025},
   volume = {57},
   year = {2025}
}

TY  - JOUR
ID  - 2487017
AU  - Dinis-Ribeiro, Mário - Libânio, Diogo - Uchima, Hugo - Spaander, Manon C W - Bornschein, Jan - Matysiak-Budnik, Tamara - Tziatzios, Georgios - Santos-Antunes, João - Areia, Miguel - Chapelle, Nicolas - Esposito, Gianluca - Fernandez-Esparrach, Gloria - Kunovský, Lumír - Garrido, Mónica - Tacheci, Ilja - Link, Alexander - Marcos, Pedro - Marcos-Pinto, Ricardo - Moreira, Leticia - Pereira, Ana Carina - Pimentel-Nunes, Pedro - Romanczyk, Marcin - Fontes, Filipa - Hassan, Cesare - Bisschops, Raf - Feakins, Roger - Schulz, Christian - Triantafyllou, Konstantinos - Carneiro, Fatima - Kuipers, Ernst J
PY  - 2025
TI  - Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025
JF  - Endoscopy
VL  - 57
IS  - 05
SP  - 504-554
EP  - 504-554
PB  - GEORG THIEME VERLAG KG
SN  - 0013726X
KW  - early neoplasia of the stomach
KW  - epithelial precancerous conditions
UR  - https://www.esge.com/management-of-epithelial-precancerous-conditions-and-early-neoplasia-of-the-stomach-maps-iii-esge-ehmsg-esp-guideline-update-2025
N2  - At a population level, the European Society of Gastrointestinal Endoscopy (ESGE), the European Helicobacter and Microbiota Study Group (EHMSG), and the European Society of Pathology (ESP) suggest endoscopic screening for gastric cancer (and precancerous conditions) in high-risk regions (age-standardized rate [ASR] > 20 per 100 000 person-years) every 2 to 3 years or, if cost–effectiveness has been proven, in intermediate risk regions (ASR 10–20 per 100 000 person-years) every 5 years, but not in low-risk regions (ASR < 10). ESGE/EHMSG/ESP recommend that irrespective of country of origin, individual gastric risk assessment and stratification of precancerous conditions is recommended for first-time gastroscopy. ESGE/EHMSG/ESP suggest that gastric cancer screening or surveillance in asymptomatic individuals over 80 should be discontinued or not started, and that patients’ comorbidities should be considered when treatment of superficial lesions is planned.
ER  -

DINIS-RIBEIRO, Mário; Diogo LIB$\backslash$\^{}ANIO; Hugo UCHIMA; Manon C W SPAANDER; Jan BORNSCHEIN; Tamara MATYSIAK-BUDNIK; Georgios TZIATZIOS; João SANTOS-ANTUNES; Miguel AREIA; Nicolas CHAPELLE; Gianluca ESPOSITO; Gloria FERNANDEZ-ESPARRACH; Lumír KUNOVSKÝ; Mónica GARRIDO; Ilja TACHECI; Alexander LINK; Pedro MARCOS; Ricardo MARCOS-PINTO; Leticia MOREIRA; Ana Carina PEREIRA; Pedro PIMENTEL-NUNES; Marcin ROMANCZYK; Filipa FONTES; Cesare HASSAN; Raf BISSCHOPS; Roger FEAKINS; Christian SCHULZ; Konstantinos TRIANTAFYLLOU; Fatima CARNEIRO a Ernst J KUIPERS. Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025. \textit{Endoscopy}. STUTTGART: GEORG THIEME VERLAG KG, 2025, roč.~57, č.~05, s.~504-554. ISSN~0013-726X. Dostupné z: https://doi.org/10.1055/a-2529-5025.

Přehled o publikaci